As of 31 Dec 2025, 25 institutional investors reported holding 702,854 shares of LISATA THERAPEUTICS, INC. - COM (LSTA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 702,854 | $1,307,418 | -$8,228 | $1.86 | 25 |
| 2025 Q3 | 739,132 | $1,934,956 | -$115,474 | $2.62 | 21 |
| 2025 Q2 | 782,450 | $2,258,585 | +$396 | $2.90 | 19 |
| 2025 Q1 | 783,317 | $1,841,764 | -$20,009 | $2.35 | 21 |
| 2024 Q4 | 785,678 | $2,334,670 | +$56,439 | $2.98 | 19 |
| 2024 Q3 | 766,124 | $2,295,971 | +$40,297 | $3.00 | 18 |
| 2024 Q2 | 752,310 | $2,610,221 | +$51,005 | $3.47 | 20 |
| 2024 Q1 | 738,701 | $2,302,627 | -$4,776 | $3.12 | 19 |
| 2023 Q4 | 742,013 | $2,025,135 | +$156,383 | $2.73 | 19 |
| 2023 Q3 | 684,732 | $1,460,223 | -$18,283 | $2.14 | 19 |
| 2023 Q2 | 680,704 | $2,512,454 | +$152,750 | $3.70 | 20 |
| 2023 Q1 | 639,647 | $2,075,677 | -$218,040 | $3.24 | 18 |
| 2022 Q4 | 724,853 | $1,832,551 | +$27,570 | $2.53 | 19 |
| 2022 Q3 | 469,894 | $2,170,000 | +$2,170,000 | $4.63 | 12 |